Cargando…
Immunophenotype Rearrangement in Response to Tumor Excision May Be Related to the Risk of Biochemical Recurrence in Prostate Cancer Patients
Background: Prostate cancer (PCa) is known to exhibit a wide spectrum of aggressiveness and relatively high immunogenicity. The aim of this study was to examine the effect of tumor excision on immunophenotype rearrangements in peripheral blood and to elucidate if it is associated with biochemical re...
Autores principales: | Bosas, Paulius, Zaleskis, Gintaras, Dabkevičiene, Daiva, Dobrovolskiene, Neringa, Mlynska, Agata, Tikuišis, Renatas, Ulys, Albertas, Pašukoniene, Vita, Jarmalaitė, Sonata, Jankevičius, Feliksas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396861/ https://www.ncbi.nlm.nih.gov/pubmed/34442004 http://dx.doi.org/10.3390/jcm10163709 |
Ejemplares similares
-
Letter to the Editor: No immunophenotyping in peripheral blood of prostate cancer patients treated with neoadjuvant Rituximab?
por: Bosas, Paulius, et al.
Publicado: (2020) -
LMTK2 as Potential Biomarker for Stratification between Clinically Insignificant and Clinically Significant Prostate Cancer
por: Vezelis, Alvydas, et al.
Publicado: (2021) -
Urinary DNA as a Tool for Germline and Somatic Mutation Detection in Castration-Resistant Prostate Cancer Patients
por: Januskevicius, Tomas, et al.
Publicado: (2023) -
Clinical Significance of ADAMTS19, BMP7, SIM1, and SFRP1 Promoter Methylation in Renal Clear Cell Carcinoma
por: Kubiliute, Raimonda, et al.
Publicado: (2021) -
Promoter Methylation of PRKCB, ADAMTS12, and NAALAD2 Is Specific to Prostate Cancer and Predicts Biochemical Disease Recurrence
por: Daniunaite, Kristina, et al.
Publicado: (2021)